Marcq-en-Baroeul, France

Bertrand Dirie


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bertrand Dirie: Innovator in Mycobacterial Infection Treatment

Introduction

Bertrand Dirie is a notable inventor based in Marcq-en-Baroeul, France. He has made significant contributions to the field of medicine, particularly in the treatment of mycobacterial infections such as tuberculosis and leprosy. His innovative work has led to the development of a patent that enhances the efficacy of antibiotics.

Latest Patents

Dirie's most recent patent is titled "Compounds having a potentiating effect on the activity of ethionamide and uses thereof." This invention focuses on the use of compounds that enhance the activity of antibiotics that are activatable via the EthA enzymatic pathway. The patent outlines the preparation of a medicament aimed at preventing and treating mycobacterial infections. It also includes pharmaceutical compositions that combine these compounds with antibiotics, showcasing their potential in combating serious infections.

Career Highlights

Throughout his career, Bertrand Dirie has worked with prestigious institutions such as the Institut Pasteur de Lille and the Centre National de la Recherche Scientifique. His work in these organizations has allowed him to advance his research and contribute to significant medical breakthroughs.

Collaborations

Dirie has collaborated with notable colleagues, including Benoît Deprez and Nicolas Willand. These partnerships have fostered a collaborative environment that has been essential for his research and development efforts.

Conclusion

Bertrand Dirie's innovative contributions to the treatment of mycobacterial infections highlight his role as a significant inventor in the medical field. His patent work demonstrates the potential for new therapeutic approaches to combat serious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…